VKTX vs. MCK

Last updated Jun 9, 2026

VKTX (Viking Therapeutics, Inc.) and MCK (McKesson Corporation) are both stocks. Both are in the Healthcare sector — VKTX in Biotechnology, MCK in Medical Distribution. Over the past 10 years, VKTX returned 36.31%/yr vs 16.13%/yr for MCK. At a 0.11 correlation, their price movements are largely independent.

Performance

VKTX vs. MCK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Viking Therapeutics, Inc. (VKTX) and McKesson Corporation (MCK). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, VKTX achieves a -16.88% return, which is significantly lower than MCK's -6.36% return. Over the past 10 years, VKTX has outperformed MCK with an annualized return of 36.31%, while MCK has yielded a comparatively lower 16.13% annualized return.

VKTX

• 1D: 2.78%
• 1M: -6.67%
• YTD: -16.88%
• 6M: -23.01%
• 1Y: 5.07%
• 3Y*: 6.41%
• 5Y*: 39.22%
• 10Y*: 36.31%

MCK

• 1D: -1.16%
• 1M: 4.27%
• YTD: -6.36%
• 6M: -3.74%
• 1Y: 7.98%
• 3Y*: 25.42%
• 5Y*: 32.82%
• 10Y*: 16.13%

*Multi-year figures are annualized to reflect compound growth (CAGR)

VKTX vs. MCK - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
VKTX Viking Therapeutics, Inc.	-16.88%	-12.57%	116.23%	97.98%	104.35%	-18.29%	-29.80%	4.84%	88.42%	241.18%
MCK McKesson Corporation	-6.36%	44.54%	23.67%	24.13%	51.82%	44.23%	27.06%	26.72%	-28.40%	11.95%

Correlation

The correlation between VKTX and MCK is -0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.02
Correlation (3Y) Calculated over the trailing 3-year period	0.01
Correlation (5Y) Calculated over the trailing 5-year period	0.06
Correlation (10Y) Calculated over the trailing 10-year period	0.13
Correlation (All Time) Calculated using the full available price history since Apr 30, 2015	0.11

The correlation between VKTX and MCK shifts across timeframes, from -0.02 (1 year) to 0.13 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap VKTX : $3.38B MCK : $94.07B
EPS VKTX : -$4.16 MCK : $38.38
PB Ratio VKTX : 6.73 MCK : 13.60
Total Revenue (TTM) VKTX : $0.00 MCK : $403.43B
Gross Profit (TTM) VKTX : -$208.00K MCK : $14.55B
EBITDA (TTM) VKTX : -$501.77M MCK : $6.91B

Return for Risk

VKTX vs. MCK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VKTX

VKTX Risk / Return Rank: 46
VKTX Sharpe Ratio Rank: 44
VKTX Sortino Ratio Rank: 47
VKTX Omega Ratio Rank: 49
VKTX Calmar Ratio Rank: 45
VKTX Martin Ratio Rank: 45

MCK

MCK Risk / Return Rank: 49
MCK Sharpe Ratio Rank: 52
MCK Sortino Ratio Rank: 47
MCK Omega Ratio Rank: 47
MCK Calmar Ratio Rank: 49
MCK Martin Ratio Rank: 51

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VKTX vs. MCK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Viking Therapeutics, Inc. (VKTX) and McKesson Corporation (MCK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	VKTX	MCK	Difference
Sharpe ratio: Return per unit of total volatility	0.07	0.28	-0.21
Sortino ratio: Return per unit of downside risk	0.63	0.65	-0.01
Omega ratio: Gain probability vs. loss probability	1.10	1.08	+0.01
Calmar ratio: Return relative to maximum drawdown	0.11	0.29	-0.18
Martin ratio: Return relative to average drawdown	0.23	0.79	-0.57
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

VKTX vs. MCK - Sharpe Ratio Comparison

The current VKTX Sharpe Ratio is 0.07, which is lower than the MCK Sharpe Ratio of 0.28. The chart below compares the historical Sharpe Ratios of VKTX and MCK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	VKTX	MCK	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.07	0.28	-0.21
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.39	1.36	-0.98
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.38	0.56	-0.19
Sharpe Ratio (All Time) Calculated using the full available price history	0.11	0.44	-0.33

Drawdowns

VKTX vs. MCK - Drawdown Comparison

The maximum VKTX drawdown since its inception was -90.41%, which is greater than MCK's maximum drawdown of -82.84%. Use the drawdown chart below to compare losses from any high point for VKTX and MCK.

Drawdown Indicators

	VKTX	MCK	Difference
Max Drawdown Largest peak-to-trough decline	-90.41%	-82.84%	-7.57%
Max Drawdown (1Y) Largest decline over 1 year	-45.14%	-27.17%	-17.97%
Max Drawdown (3Y) Largest decline over 3 years	-78.86%	-27.17%	-51.69%
Max Drawdown (5Y) Largest decline over 5 years	-78.86%	-27.17%	-51.69%
Max Drawdown (10Y) Largest decline over 10 years	-89.26%	-44.23%	-45.03%
Current Drawdown Current decline from peak	-69.06%	-22.92%	-46.14%
Average Drawdown Average peak-to-trough decline	-60.02%	-28.65%	-31.37%
Ulcer Index Depth and duration of drawdowns from previous peaks	22.54%	10.06%	+12.48%

Volatility

VKTX vs. MCK - Volatility Comparison

Viking Therapeutics, Inc. (VKTX) has a higher volatility of 14.20% compared to McKesson Corporation (MCK) at 6.94%. This indicates that VKTX's price experiences larger fluctuations and is considered to be riskier than MCK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	VKTX	MCK	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.20%	6.94%	+7.26%
Volatility (6M) Calculated over the trailing 6-month period	40.45%	22.76%	+17.69%
Volatility (1Y) Calculated over the trailing 1-year period	74.12%	29.16%	+44.96%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	101.63%	24.20%	+77.43%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	97.07%	28.82%	+68.25%

Dividends

VKTX vs. MCK - Dividend Comparison

VKTX has not paid dividends to shareholders, while MCK's dividend yield for the trailing twelve months is around 0.43%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
MCK McKesson Corporation	0.43%	0.37%	0.47%	0.50%	0.54%	0.72%	0.95%	1.16%	1.32%	0.80%	0.80%	0.53%
VKTX Viking Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both VKTX and MCK in my portfolio?

VKTX and MCK have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, VKTX or MCK?

VKTX has higher volatility (14.20%) compared to MCK (6.94%). In terms of maximum drawdown, VKTX dropped -90.41% vs MCK's -82.84%.

Which has better risk-adjusted returns?

MCK currently has the higher Sharpe Ratio (0.28 vs 0.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.